BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17725809)

  • 1. Mortality modeling of early detection programs.
    Lee SJ; Zelen M
    Biometrics; 2008 Jun; 64(2):386-95. PubMed ID: 17725809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A stochastic model for predicting the mortality of breast cancer.
    Lee S; Zelen M
    J Natl Cancer Inst Monogr; 2006; (36):79-86. PubMed ID: 17032897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of length biased sampling of unobserved sojourn times on the survival distribution when disease is screen detected.
    Kafadar K; Prorok PC
    Stat Med; 2009 Jul; 28(16):2116-46. PubMed ID: 19424959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying the predictive performance of prognostic models for censored survival data with time-dependent covariates.
    Schoop R; Graf E; Schumacher M
    Biometrics; 2008 Jun; 64(2):603-10. PubMed ID: 17764480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative survival analysis in R.
    Pohar M; Stare J
    Comput Methods Programs Biomed; 2006 Mar; 81(3):272-8. PubMed ID: 16510208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An early- and late-stage convolution model for disease natural history.
    Pinsky PF
    Biometrics; 2004 Mar; 60(1):191-8. PubMed ID: 15032789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of service screening on breast cancer mortality rates.
    Cox B
    Eur J Cancer Prev; 2008 Aug; 17(4):306-11. PubMed ID: 18562953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marginal analysis of correlated failure time data with informative cluster sizes.
    Cong XJ; Yin G; Shen Y
    Biometrics; 2007 Sep; 63(3):663-72. PubMed ID: 17825000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality of Parkinson's disease by Hoehn-Yahr stage from community-based and clinic series [Keelung Community-based Integrated Screening (KCIS) no. 17)].
    Liou HH; Wu CY; Chiu YH; Yen AM; Chen RC; Chen TF; Chen CC; Hwang YC; Wen YR; Chen TH
    J Eval Clin Pract; 2009 Aug; 15(4):587-91. PubMed ID: 19674213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental design issues for the early detection of disease: novel designs.
    Hu P; Zelen M
    Biostatistics; 2002 Sep; 3(3):299-313. PubMed ID: 12933599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the united states: a population-based study.
    Shaib YH; Davila JA; Henderson L; McGlynn KA; El-Serag HB
    J Clin Gastroenterol; 2007; 41(10):911-7. PubMed ID: 18090160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multilevel mixture cure models with random effects.
    Lai X; Yau KK
    Biom J; 2009 Jun; 51(3):456-66. PubMed ID: 19588451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flexible parametric models for relative survival, with application in coronary heart disease.
    Nelson CP; Lambert PC; Squire IB; Jones DR
    Stat Med; 2007 Dec; 26(30):5486-98. PubMed ID: 17893893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
    Havrilesky LJ; Sanders GD; Kulasingam S; Myers ER
    Gynecol Oncol; 2008 Nov; 111(2):179-87. PubMed ID: 18722004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Competitive risks and multi-state models in epidemiology].
    Commenges D
    Rev Epidemiol Sante Publique; 1999 Dec; 47(6):605-11. PubMed ID: 10673594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating and modeling the cure fraction in population-based cancer survival analysis.
    Lambert PC; Thompson JR; Weston CL; Dickman PW
    Biostatistics; 2007 Jul; 8(3):576-94. PubMed ID: 17021277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic disease projections in heterogeneous ageing populations: approximating multi-state models of joint distributions by modelling marginal distributions.
    Hoogenveen RT; van Baal PH; Boshuizen HC
    Math Med Biol; 2010 Mar; 27(1):1-19. PubMed ID: 19516046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality in co-morbidity (II)--excess death rates derived from a follow-up study on 10,025 subjects divided into 4 groups with or without depression and diabetes mellitus.
    Milano AF; Singer RB
    J Insur Med; 2007; 39(3):160-6. PubMed ID: 18251374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian transformation cure frailty models with multivariate failure time data.
    Yin G
    Stat Med; 2008 Dec; 27(28):5929-40. PubMed ID: 18618427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periodically forced discrete-time SIS epidemic model with disease induced mortality.
    Franke JE; Yakubu AA
    Math Biosci Eng; 2011 Apr; 8(2):385-408. PubMed ID: 21631136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.